Related by context. Frequent words. (Click for all words.) 79 Meets Primary Endpoint 76 Improves Survival 75 Significantly Improved 74 Clinical Trial Results 74 Receives Orphan Drug Designation 74 Single Dose 74 Drug Candidate 73 Phase III Trial 73 Completes Enrollment 73 Chronic Hepatitis C 72 Pulmonary Arterial Hypertension 72 Patient Enrollment 72 Significantly Reduces 72 Preclinical Data 72 Overactive Bladder 72 Significantly Improves 72 Low Dose 72 Phase III Clinical Trial 72 Recombinant Human 72 Study Demonstrates 71 Monotherapy 71 FDA Accepts 71 Patients Treated 71 Reduces Risk 71 Heart Failure Patients 71 Presents Positive 71 Drug Shows Promise 71 Initiates Phase II 71 Pivotal Phase III 71 Allergic Rhinitis 71 Etanercept 70 Well Tolerated 70 FDA Clears 70 Nephrol 70 Diabetic Patients 70 Significantly Reduced 70 Patients Undergoing 70 Elderly Patients 70 Prostate Cancer Patients 70 Chronic Heart Failure 70 Pediatric Patients 70 Coadministration 70 Initiate Phase 70 Chronic Hepatitis B 70 Combination Therapy 70 Obstet Gynecol 70 J Am Coll 70 Venous Thromboembolism 70 Announces FDA Clearance 69 Tumor Growth 69 Diabetic Neuropathy 69 Benign Prostatic Hyperplasia 69 Epratuzumab 69 Myelofibrosis 69 Pivotal Phase 69 Renal Cell Carcinoma 69 Post Operative 69 Lenalidomide 69 Acute Ischemic Stroke 69 Generic Version 69 J Pediatr 69 Advanced Prostate Cancer 69 Drug Resistant 69 CHEAP ONLINE PHARMACY LOW 69 Golimumab 68 Crit Care Med 68 Pivotal Trial 68 Cardiol 68 Metastatic Melanoma 68 Pivotal Study 68 Antipsychotic 68 Extended Release 68 Urinary Incontinence 68 Natalizumab 68 Commences Phase 68 refractory chronic lymphocytic 68 Arch Neurol 68 Inhaled Insulin 67 Oncol 67 Chronic Lymphocytic Leukemia 67 Generalized Anxiety Disorder 67 Cyclophosphamide 67 Metastatic Colorectal Cancer 67 Inflammatory Diseases 67 Dermatol 67 J Am Acad 67 Prostate Cancer Treatment 67 Anticoagulation 67 Blood Thinner 67 Psychiatric Disorders 67 Meta Analysis 67 Cognitive Impairment 67 Epidermal Growth Factor Receptor 67 Inhibits 67 II Clinical Trial 67 Eculizumab 67 Aliskiren 67 J Am Soc 67 Postmenopausal Women 67 Capecitabine 67 Corticosteroid